Search Results

• • 38 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Surveillance for control of antimicrobial resistance

  Authors:Evelina Tacconelli, Frangiscos Sifakis, Stephan Harbarth, Remco Schrijver, Maaike van Mourik, Andreas Voss, et al.From:The Lancet Infectious Diseases (Vol. 18, Issue 3) Peer-Reviewed

  Mar. 2018507 words Article

   Abstract Only

• Clinical features and molecular epidemiology of CMY-type (beta)-lactamase-producing Escherichia coli

  Authors:Hanna E. Sidjabat, David L. Paterson, Zubair A. Qureshi, Jennifer M. Adams-Haduch, Alexandra O'Keefe, Alvaro Pascual, et al.From:Clinical Infectious Diseases (Vol. 48, Issue 6) Peer-Reviewed

  Mar. 15, 2009 Clinical report

   Citation Only

• A Change in the epidemiology of infections due to extended-spectrum [beta]-lactamase-producing organisms

  Authors:Jesus Rodriguez-Bano and David L. PatersonFrom:Clinical Infectious Diseases (Vol. 42, Issue 7) Peer-Reviewed

  Apr. 1, 2006 Editorial 1700L

   Citation Only

• A predictive model of mortality in patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae

  Authors:Belen Gutierrez-Gutierrez, Elena Salamanca, Marina de Cueto, Po-Ren Hsueh, Pierluigi Viale, Jose Ramon Pano-Pardo, et al.From:Mayo Clinic Proceedings (Vol. 91, Issue 10) Peer-Reviewed

  Oct. 20165,234 words Report 1380LAbstract Objective: To develop a score to predict mortality in patients with bloodstream infections (BSIs) due to carbapenemase-producing Enterobacteriaceae (CPE). Patients and Methods: A multinational...

• Erratum to: Should we take into account ESBLs in empirical antibiotic treatment?

  Authors:Matteo Bassetti and Jesús Rodríguez-BañoFrom:Intensive Care Medicine (Vol. 43, Issue 2) Peer-Reviewed

  Feb. 2017111 words Correction notice, B... 1740LAuthor(s): Matteo Bassetti 1 3, Jesús Rodríguez-Baño 2 Author Affiliations: (1) grid.411492.b, Infectious Diseases Division, Santa Maria Misericordia University Hospital, , Udine, Italy (2) grid.9224.d,...

• Community infections caused by extended-spectrum [beta]-lactamase-producing Escherichia coli

  Authors:Jesus Rodriguez-Bano, Juan C. Alcala, Jose M. Cisneros, Fabio Grill, Antonio Oliver, Juan P. Horcajada, et al.From:Archives of Internal Medicine (Vol. 168, Issue 17) Peer-Reviewed

  Sept. 22, 2008 Clinical report

   Citation Only

• In Reply--Statin Use Associated With a Decreased Risk of Community-Acquired Staphylococcus aureus Bacteremia

  Authors:Jesper Smit, Henrik Carl Schonheyder, Henrik Nielsen, Mette Sogaard, Luis Eduardo Lopez-Cortes, Jesus Rodriguez-Bano, et al.From:Mayo Clinic Proceedings (Vol. 93, Issue 4) Peer-Reviewed

  Apr. 2018274 words Brief article, Lette... 1530LWe appreciate Dr Ko and colleagues' interesting reflections on our findings concerning the influence of statin use on the risk of community-acquired Staphylococcus aureus bacteremia (CA-SAB). Because the aim of our...

• Effect of adequate single-drug vs combination antimicrobial therapy on mortality in pseudomonas aeruginosa bloodstream infections: a post hoc analysis of a prospective cohort

  Authors:Carmen Pena, Cristina Suarez, Alain Ocampo-Sosa, Javier Murillas, Benito Almirante, Virginia Pomar, et al.From:Clinical Infectious Diseases (Vol. 57, Issue 2) Peer-Reviewed

  July 15, 2013 Report

   Citation Only

• Daptomycin or vancomycin for methicillin-resistant staphylococcus aureus with a vancomycin minimum inhibitory concentration

  Authors:Luis E. Lopez-Cortes, Alvaro Pascual, and Jesus Rodriguez-BanoFrom:Clinical Infectious Diseases (Vol. 54, Issue 9) Peer-Reviewed

  May 1, 2012 Report

   Citation Only

• Community-onset bacteremia due to extended-spectrum (beta)-lactamase-producing Escherichia coli: risk factors and prognosis

  Authors:Jesus Rodriguez-Bano, Encarnacion Picon, Paloma Gijon, Jose Ramon Hernandez, Maite Ruiz, Carmen Pena, et al.From:Clinical Infectious Diseases (Vol. 50, Issue 1) Peer-Reviewed

  Jan. 1, 2010 Clinical report

   Citation Only

• Effect of Statin Therapy in the Outcome of Bloodstream Infections Due to Staphylococcus aureus: A Prospective Cohort Study

  Authors:Luis E. Lopez-Cortes, Juan Galvez-Acebal, Maria D. del Toro, Carmen Velasco, Marina de Cueto, Francisco J. Caballero, et al.From:PLoS ONE (Vol. 8, Issue 12) Peer-Reviewed

  Dec. 23, 20134,747 words Clinical report 1360LAuthor(s): Luis E. López-Cortés 1, Juan Gálvez-Acebal 1,2,4, María D. del Toro 1,2,4, Carmen Velasco 2,3, Marina de Cueto 1,2, Francisco J. Caballero 2, Miguel A. Muniain 1,2,4,Álvaro Pascual 1,2,3, Jesús Rodríguez-Baño...

• Overproduction of outer membrane protein a by acinetobacter baumannii as a risk factor for nosocomial pneumonia, bacteremia, and mortality rate increase

  Authors:Viviana Sanchez-Encinales, Rocio Alvarez-Marin, Maria Eugenia Pachon-Ibanez, Felipe Fernandez-Cuenca, Alvaro Pascual, Jose Garnacho-Montero, et al.From:Journal of Infectious Diseases (Vol. 215, Issue 6) Peer-Reviewed

  Mar. 15, 2017 Article

   Citation Only

• Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A (H1N1) virus infection

  Authors:Diego Viasus, Jose Ramon Pano-Pardo, Jeronimo Pachon, Melchor Riera, Francisco Lopez-Medrano, Antoni Payeras, et al.From:Chest (Vol. 140, Issue 4) Peer-Reviewed

  Oct. 2011 Clinical report

   Citation Only

• Pneumonia complicating pandemic (H1N1) 2009: risk factors, clinical features, and outcomes

  Authors:Diego Viasus, Jose Ramon Pano-Pardo, Jeronimo Pachon, Melchor Riera, Francisco Lopez-Medrano, Antoni Payeras, et al.From:Medicine (Vol. 90, Issue 5) Peer-Reviewed

  Sept. 2011 Report

   Citation Only

• Bacteremia due to extended-spectrum (beta)-lactamase-producing escherichia coli in the CTX-M era: a new clinical challenge

  Authors:Jesus Rodriguez-Bano, Maria D. Navarro, Luisa Romero, Miguel A. Muniain, Marina de Cueto, Maria J. Rios, et al.From:Clinical Infectious Diseases (Vol. 43, Issue 11) Peer-Reviewed

  Dec. 1, 2006 Article

   Citation Only

• Clinical and molecular epidemiology of extended-spectrum [beta]-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control

  Authors:Jesus Rodriguez-Bano, Maria D. Navarro, Luisa Romero, Miguel A. Muniain, Evelio J. Perea, Ramon Perez-Cano, et al.From:Clinical Infectious Diseases (Vol. 42, Issue 1) Peer-Reviewed

  Jan. 1, 2006 Article

   Citation Only

• Impact of an evidence-based bundle intervention in the quality-of-care management and outcome of Staphylococcus aureus bacteremia

  Authors:Luis E. Lopez-Cortes, Maria Dolores del Toro, uan Galvez-Acebal, Elena Bereciartua-Bastarrica, Maria Carmen Farinas, Mercedes Sanz-Franco, et al.From:Clinical Infectious Diseases (Vol. 57, Issue 9) Peer-Reviewed

  Nov. 1, 2013 Report

   Citation Only

• Risk factors for community-acquired infections caused by extended-spectrum (beta)-lactamase-producing Escherichia coli

  Authors:Keli Cristine Reiter, Sandra C. Fuchs, Nemora T. Barcellos, Alexandre P. Zavascki, Jesus Rodriguez-Bano, and Alvaro PascualFrom:Archives of Internal Medicine (Vol. 169, Issue 8) Peer-Reviewed

  Apr. 27, 2009 Letter to the editor

   Citation Only

• Global dissemination of a multidrug resistant Escherichia coli clone.

  Authors:Nicola K. Petty, Nouri L. Ben Zakour, Mitchell Stanton-Cook, Elizabeth Skippington, Makrina Totsika, Brian M. Forde, et al.From:Proceedings of the National Academy of Sciences of the United States (Vol. 111, Issue 15) Peer-Reviewed

  Apr. 15, 2014255 words Report, Author abstr...

   Abstract Only

• Influence of virulence genotype and resistance profile in the mortality of Pseudomonas aeruginosa bloodstream infections

  Authors:Carmen Pena, Gabriel Cabot, Silvia Gomez-Zorrilla, Laura Zamorano, Alain Ocampo-Sosa, Javier Murillas, et al.From:Clinical Infectious Diseases (Vol. 60, Issue 4) Peer-Reviewed

  Feb. 15, 2015 Report

   Citation Only